ENTO

Entero Therapeutics
ENTO

Overview Fund Trends Analyst Outlook Journalist POV

7 hedge funds and large institutions have $332K invested in Entero Therapeutics in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$128K
2
+$16K
3
+$9.44K
4
UBS Group
UBS Group
Switzerland
+$5.5K

Top Sellers

1
-$13.4K
2
-$9K
3
-$2K
4
US Bancorp
US Bancorp
Minnesota
-$149
5
MCC
Money Concepts Capital
Florida
-$29
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$241K
2
$35K
3
$31.6K
4
$12K
5
$11K
6
$1.06K
7
$89
8
$64
9
$59
10
$3
11
$2
12
–
13
–
14
–
15
–
16
–
17
–